The VitalFlow extracorporeal membrane oxygenation (ECMO) system within the Cardiac Surgery portfolio won CE mark in June. It aims to bridge the gap between bedside care and intra-hospital transport through a simple, fully integrated portfolio.
Medtronic — one of the largest medtech companies in the world — said it plans to officially launch VitalFlow in Europe at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting from October 8-11 in Copenhagen, Denmark.